methylene blue

メチレンブルー

WordNet

1. used to signify the Union forces in the American Civil War (who wore blue uniforms); "a ragged blue line"
2. blue color or pigment; resembling the color of the clear sky in the daytime; "he had eyes of bright blue" (同)blueness
3. any of numerous small butterflies of the family Lycaenidae
4. blue clothing; "she was wearing blue"
5. any organization or party whose uniforms or badges are blue; "the Union army was a vast blue"
6. of the color intermediate between green and violet; having a color similar to that of a clear unclouded sky; "Octobers bright blue weather"- Helen Hunt Jackson; "a blue flame"; "blue haze of tobacco smoke" (同)bluish, blueish
7. causing dejection; "a blue day"; "the dark days of the war"; "a week of rainy depressing weather"; "a disconsolate winter landscape"; "the first dismal dispiriting days of November"; "a dark gloomy day"; "grim rainy weather" (同)dark, dingy, disconsolate, dismal, gloomy, grim, sorry, drab, drear, dreary
8. suggestive of sexual impropriety; "a blue movie"; "blue jokes"; "he skips asterisks and gives you the gamy details"; "a juicy scandal"; "a naughty wink"; "naughty words"; "racy anecdotes"; "a risque story"; "spicy gossip" (同)gamy, gamey, juicy, naughty, racy, risque, spicy
9. morally rigorous and strict; "the puritan work ethic"; "puritanic distaste for alcohol"; "she was anything but puritanical in her behavior" (同)puritanic, puritanical
10. turn blue
11. a state of depression; "he had a bad case of the blues" (同)blue devils, megrims, vapors, vapours
12. a type of folksong that originated among Black Americans at the beginning of the 20th century; has a melancholy sound from repeated use of blue notes
13. a process that makes something blue (or bluish) (同)blueing
14. used to whiten laundry or hair or give it a bluish tinge (同)blueing, blue

PrepTutorEJDIC

1. 『青い』,あい色の / 青黒い / 《話》陰気な,憂うつな / 〈U〉『青色』,あい色;青色の着物 / 〈U〉〈C〉青色絵の具,あい色染料 / 《the~》《詩》青空,青い海 / 《the blues》《話》気のふさぎ,うれいの色 / 《the blues》《ときに単数扱い》(ジャズ音楽の)ブルース / …'を'青色にする
2. = bluing

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/10/20 11:16:41」(JST)

wiki en

[Wiki en表示]

Methylene blue

Systematic (IUPAC) name
3,7-bis(Dimethylamino)-phenothiazin-5-ium chloride
Clinical data
AHFS/Drugs.com	Monograph
Pregnancy category	US: X
Routes of administration	oral
Legal status
Legal status	investigational
Identifiers
CAS Number	61-73-4 Y
ATC code	none
PubChem	CID 6099
ChemSpider	5874 Y
ChEBI	CHEBI:6872 Y
ChEMBL	CHEMBL405110 Y
Chemical data
Formula	C16H18ClN3S
Molar mass	319.85 g/mol
SMILES CN(C)c1ccc2c(c1)sc-3cc(=[N+](C)C)ccc3n2.[Cl-]
InChI InChI=1S/C16H18N3S.ClH/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;/h5-10H,1-4H3;1H/q+1;/p-1 Y Key:CXKWCBBOMKCUKX-UHFFFAOYSA-M Y
(verify)

Methylene blue (CI 52015), also known as methylthioninium chloride, has many uses in biology and chemistry; for example, it can be used as a stain and as a medication. Methylene blue should not be confused with methyl blue, another histology stain, new methylene blue, nor with the methyl violets often used as pH indicators.

Methylene blue is a heterocyclic aromatic chemical compound (a phenothiazine derivative) with the chemical formula C₁₆H₁₈N₃SCl. At room temperature it appears as a solid, odorless, dark green powder, that yields a blue solution when dissolved in water. The hydrated form has 3 molecules of water per unit of methylene blue. Methylene blue has a pHa of 3 in water(10g/l) at 25 °C (77 °F).

Methylene blue was first prepared as a stain in 1876 by German chemist Heinrich Caro. It was discovered to be an antidote to carbon monoxide poisoning and cyanide poisoning in 1932 by Matilda Moldenhauer Brooks.

It is on the World Health Organization's List of Essential Medicines.

Medical uses

Methylene blue is a component of a frequently prescribed urinary analgesic/anti-infective/anti-spasmodic known as "Prosed", a combination of drugs which also contains phenyl salicylate, benzoic acid, hyoscyamine sulfate, and methenamine (aka hexamethylenetetramine and not to be confused with 'methanamine').

Combined with light

Methylene blue combined with light has been used to treat resistant plaque psoriasis, AIDS-related Kaposi's sarcoma, West Nile virus, and to inactivate staphylococcus aureus, HIV-1, Duck hepatitis B virus, adenovirus vectors, and hepatitis C. Phenothiazine dyes and light have been known to have virucidal properties for over 70 years. In some circumstances, the combination can cause DNA damage that may lead to cancer.

Methemoglobinemia

While many texts indicate that methylene blue has oxidizing agent properties, its effects as an oxidizing agent occur only at very high doses. At pharmacologic doses it has reducing agent properties. It is owing to this reason that methylene blue is employed as a medication for the treatment of methemoglobinemia. This can arise from ingestion of certain pharmaceuticals, toxins, or broad beans. Normally, through the NADH or NADPH dependent methemoglobin reductase enzymes, methemoglobin is reduced back to hemoglobin. When large amounts of methemoglobin occur secondary to toxins, methemoglobin reductases are overwhelmed. Methylene blue, when injected intravenously as an antidote, is itself first reduced to leucomethylene blue, which then reduces the heme group from methemoglobin to hemoglobin. Methylene blue can reduce the half life of methemoglobin from hours to minutes. At high doses, however, methylene blue actually induces methemoglobinemia, reversing this pathway.

Hypotension

Methylene blue also blocks accumulation of cyclic guanosine monophosphate (cGMP) by inhibiting the enzyme guanylate cyclase: this action results in reduced responsiveness of vessels to cGMP-dependent vasodilators like nitric oxide and carbon monoxide. Cardiac surgical teams have found this very useful in the treatment of extremely low blood pressure (hypotension) which may occur during heart surgery requiring cardiac bypass. Similar use is noted in the treatment of hypotension associated with overwhelming infections (sepsis).

Cyanide poisoning

Since its reduction potential is similar to that of oxygen and can be reduced by components of the electron transport chain, large doses of methylene blue are sometimes used as an antidote to potassium cyanide poisoning, a method first successfully tested in 1933 by Dr. Matilda Moldenhauer Brooks in San Francisco, although first demonstrated by Bo Sahlin of Lund University, in 1926.

Dye or stain

Methylene blue is used in endoscopic polypectomy as an adjunct to saline or epinephrine, and is used for injection into the submucosa around the polyp to be removed. This allows the submucosal tissue plane to be identified after the polyp is removed, which is useful in determining if more tissue needs to be removed, or if there has been a high risk for perforation. Methylene blue is also used as a dye in chromoendoscopy, and is sprayed onto the mucosa of the gastrointestinal tract in order to identify dysplasia, or pre-cancerous lesions. Intravenously injected methylene blue is readily released into the urine and thus can be used to test the urinary tract for leaks or fistulas.

In surgeries such as sentinel lymph node dissections, methylene blue can be used to visually trace the lymphatic drainage of pertinent tissues. Similarly, methylene blue is added to bone cement in orthopedic operations to provide easy discrimination between native bone and cement. Additionally, methylene blue accelerates the hardening of bone cement, increasing the speed at which bone cement can be effectively applied. Methylene blue is used as an aid to visualisation/orientation in a number of medical devices, including a Surgical sealant film, TissuePatch.

When methylene blue is "polychromed" (oxidized in solution or "ripened" by fungal metabolism, as originally noted in the thesis of Dr D L Romanowsky in 1890s), it gets serially demethylated and forms all the tri, di, mono and non methyl intermediates - which are Azure B, Azure A, Azure C and thionine respectively. This is the basis of the basophilic part of the spectrum of Romanowski-Giemsa effect. If only synthetic Azure B and Eosin Y is used, it may serve as a standardized Giemsa stain; but, without methylene blue, the normal neutrophilic granules tend to overstain and look like toxic granules. On the other hand, if methylene blue is used it might help to give the normal look of neutrophil granules and may additionally also enhances the staining of nucleoli and polychromatophilic RBCs (reticulocytes).

A traditional application of methylene blue is the intravital or supravital staining of nerve fibers, an effect first described by Paul Ehrlich in 1887. A dilute solution of the dye is either injected into tissue or applied to small freshly removed pieces. The selective blue coloration develops with exposure to air (oxygen) and can be fixed by immersion of the stained specimen in an aqueous solution of ammonium molybdate. Vital methylene blue was formerly much used for examining the innervation of muscle, skin and internal organs. The mechanism of selective dye uptake is incompletely understood; vital staining of nerve fibers in skin is prevented by ouabain, a drug that inhibits the Na/K-ATPase of cell membranes.

Placebo

Methylene blue has been used as a placebo; physicians would tell their patients to expect their urine to change color and view this as a sign that their condition had improved. This same side effect makes methylene blue difficult to test in traditional placebo-controlled clinical studies.

Ifosfamide neurotoxicity

Another, less well-known use of methylene blue is its utility for treating ifosfamide neurotoxicity. Methylene blue was first reported for treatment and prophylaxis of ifosfamide neuropsychiatric toxicity in 1994. A toxic metabolite of ifosfamide, chloroacetaldehyde (CAA), disrupts the mitochondrial respiratory chain, leading to an accumulation of nicotinamide adenine dinucleotide hydrogen (NADH). Methylene blue acts as an alternative electron acceptor, and reverses the NADH inhibition of hepatic gluconeogenesis while also inhibiting the transformation of chloroethylamine into chloroacetaldehyde, and inhibits multiple amine oxidase activities, preventing the formation of CAA. The dosing of methylene blue for treatment of ifosfamide neurotoxicity varies, depending upon its use simultaneously as an adjuvant in ifosfamide infusion, versus its use to reverse psychiatric symptoms that manifest after completion of an ifosfamide infusion. Reports suggest that methylene blue up to six doses a day have resulted in improvement of symptoms within 10 minutes to several days. Alternatively, it has been suggested that intravenous methylene blue every six hours for prophylaxis during ifosfamide treatment in patients with history of ifosfamide neuropsychiatric toxicity. Prophylactic administration of methylene blue the day before initiation of ifosfamide, and three times daily during ifosfamide chemotherapy has been recommended to lower the occurrence of ifosfamide neurotoxicity.

Vasoplegic syndrome after cardiac surgery

Some literature has reported the use of methylene blue as an adjunct in the management of patients experiencing vasoplegic syndrome after cardiac surgery.

Side effects

Cardiovascular	Central Nervous System	Dermatologic	Gastrointestinal	Genito-urinary	Hematologic
• Hypertension • Precordial pain	• Dizziness • Mental confusion • Headache • Fever	• Staining of skin • Injection site necrosis (SC)	• Fecal discoloration • Nausea • Vomiting • Abdominal pain	• Discoloration of urine (doses over 80 µg) • Bladder irritation	• Anemia

Methylene blue is a monoamine oxidase inhibitor (MAOI), and if infused intravenously at doses exceeding 5 mg/kg, may precipitate serious serotonin toxicity, serotonin syndrome, if combined with any selective serotonin reuptake inhibitors (SSRIs) or other serotonin reuptake inhibitor (e.g., duloxetine, sibutramine, venlafaxine, clomipramine, imipramine).

It causes hemolytic anemia in carriers of the G6PD (favism) enzymatic deficiency.

Preparation

This compound may be prepared by treating dimethyl-4-phenylenediamine with hydrogen sulfide dissolved in hydrochloric acid, followed by oxidation with ferric chloride:

Light absorption properties

Absorption spectrum of methylene blue, in terms of the molar extinction coefficient (base 10 logarithm). In this dataset a peak absorbance of 1.7 (i.e. 98% of transmitted light absorbed) was observed with 665 nm light passing through 1 cm of 10 micromolar methylene blue solution.

Methylene blue is a potent cationic dye with maximum absorption of light around 670 nm. The specifics of absorption depend on a number of factors, including protonation, adsorption to other materials, and metachromasy - the formation of dimers and higher-order aggregates depending on concentration and other interactions:

Species	Absorption peak	Extinction coefficient (dm3/mole·cm)
MB+ (solution)	664	95000
MBH2+ (solution)	741	76000
(MB+)2 (solution)	605	132000
(MB+)3 (solution)	580	110000
MB+ (adsorbed on clay)	673	116000
MBH2+ (adsorbed on clay)	763	86000
(MB+)2 (adsorbed on clay)	596	80000
(MB+)3 (adsorbed on clay)	570	114000

Other uses

A volumetric flask of a methylene blue solution

Redox indicator

Methylene blue is widely used as a redox indicator in analytical chemistry. Solutions of this substance are blue when in an oxidizing environment, but will turn colorless if exposed to a reducing agent. The redox properties can be seen in a classical demonstration of chemical kinetics in general chemistry, the "blue bottle" experiment. Typically, a solution is made of glucose (dextrose), methylene blue, and sodium hydroxide. Upon shaking the bottle, oxygen oxidizes methylene blue, and the solution turns blue. The dextrose will gradually reduce the methylene blue to its colorless, reduced form. Hence, when the dissolved dextrose is entirely consumed, the solution will turn blue again.

Peroxide generator

Methylene blue is also a photosensitizer used to create singlet oxygen when exposed to both oxygen and light. It is used in this regard to make organic peroxides by a Diels-Alder reaction which is spin forbidden with normal atmospheric triplet oxygen.

Sulfide analysis

The formation of methylene blue after the reaction of hydrogen sulfide with dimethyl-p-phenylenediamine and iron(III) at pH 0.4 – 0.7 is used to determine by photometric measurements sulfide concentration in the range 0.020 to 1.50 mg/L (20 ppb to 1.5 ppm). The test is very sensitive and the blue coloration developing upon contact of the reagents with dissolved H₂S is stable for 60 min. Ready-to-use kits such as the Spectroquant sulfide test facilitate routine analyses. The methylene blue sulfide test is a convenient method often used in soil microbiology to quickly detect in water the metabolic activity of sulfate reducing bacteria (SRB). It should be observed that in this test, methylene blue is a product of reaction and not a reagent.

The addition of a strong reducing agent, such as ascorbic acid, to a sulfide-containing solution is sometimes used to prevent sulfide oxidation from atmospheric oxygen. Although it is certainly a sound precaution for the determination of sulfide with an ion selective electrode, it might however hamper the development of the blue color if the freshly formed methylene blue is also reduced, as described here above in the paragraph on redox indicator.

Water testing

Further information: MBAS assay

A color reaction in an acidified, aqueous methylene blue solution containing chloroform can detect anionic surfactants in a water sample. Such a test is known as an MBAS assay (methylene blue active substances assay).

The MBAS assay cannot distinguish between specific surfactants, however. Some examples of anionic surfactants are carboxylates, phosphates, sulfates, and sulfonates.

Methylene blue value of fine aggregate

Methylene blue value reflects the amount of clay minerals in aggregate samples. Methylene blue solution is successively added to fine aggregate which is being agitating in water. The presence of free dye solution can be checked with stain test on a filter paper.

Biological staining etc

In biology methylene blue is used as a dye for a number of different staining procedures, such as Wright's stain and Jenner's stain. Since it is a temporary staining technique, methylene blue can also be used to examine RNA or DNA under the microscope or in a gel: as an example, a solution of methylene blue can be used to stain RNA on hybridization membranes in northern blotting to verify the amount of nucleic acid present. While methylene blue is not as sensitive as ethidium bromide, it is less toxic and it does not intercalate in nucleic acid chains, thus avoiding interference with nucleic acid retention on hybridization membranes or with the hybridization process itself.

It can also be used as an indicator to determine whether eukaryotic cells such as yeast are alive or not. The methylene blue is reduced in viable cells leaving them unstained. However dead cells are unable to reduce the oxidized methylene blue and the cells are stained blue. Methylene blue can interfere with the respiration of the yeast as it picks up hydrogen ions made during the process.

Aquaculture

Methylene blue is used in aquaculture and by tropical fish hobbyists as a treatment for fungal infections. It can also be effective in treating fish infected with ich although a combination of malachite green and formaldehyde is far more effective against the parasitic protozoa Ichthyophthirius multifiliis. It is usually used to protect newly laid fish eggs from being infected by fungus or bacteria. This is useful when the hobbyist wants to artificially hatch the fish eggs. Methylene Blue is also very effective when used as part of a "medicated fish bath" for treatment of ammonia, nitrite, and cyanide poisoning as well as for topical and internal treatment of injured or sick fish as a "first response".

History

Methylene blue has been described as "the first fully synthetic drug used in medicine." Its use in the treatment of malaria was pioneered by Paul Guttmann and Paul Ehrlich in 1891. During this period before the first World War, researchers like Ehrlich believed that drugs and dyes worked in the same way, by preferentially staining pathogens and possibly harming them. Methylene blue continued to be used in the second World War, where it was not well liked by soldiers, who observed, "Even at the loo, we see, we pee, navy blue." Antimalarial use of the drug has recently been revived. The blue urine was used to monitor psychiatric patients' compliance with medication regimes. This led to interest - from the 1890s to the present day - in the drug's antidepressant and other psychotropic effects. It became the lead compound in research leading to the discovery of chlorpromazine.

Names

The International Nonproprietary Name (INN) of methylene blue is methylthioninium chloride.

Research

Malaria

Methylene blue was identified by Paul Ehrlich about 1891 as a possible treatment for malaria. It disappeared as an anti-malarial during the Pacific War in the tropics, since American and Allied soldiers disliked its two prominent, but reversible side effects: turning the urine blue or green, and the sclera (the whites of the eyes) blue. Interest in its use as an anti-malarial has recently been revived, especially due to its low price. Several clinical trials are in progress, trying to find a suitable drug combination. According to studies on children in Africa, it appears to have efficacy against malaria, but the attempts to combine methylene blue with chloroquine were disappointing.

Clinical trials

Methylene blue (methylthioninium chloride), under the brand name Rember, has been investigated for treatment of Alzheimer's dementia. Methylene blue is proposed to affect neurodegeneration in Alzheimer's disease via inhibition of tau protein aggregation. Methylene blue also affects dissociation of amyloids TauRx Therapeutics have reformulated the drug, under the brand name LMTX. This formulation is undergoing phase 3 clinical trials for safety and efficacy as "TRx0237".

Methylene blue might also delay senescence as one study has shown that it extended the lifespan of IMR90 fibroblasts by more than 20 population doublings. LMTX addresses some of the concerns about dose-response which were raised earlier in the study.

Methylene blue, toluidine blue, and other 3,7-diaminophenothiazinium-based redox cyclers appear to induce selective cancer cell apoptosis by NAD(P)H:quinone oxidoreductase (NQO1)-dependent bioreductive generation of cellular oxidative stress. Combined with plant auxin (indole-3-acetic acid), methylene blue has been investigated for the photodynamic treatment of cancer.

See also

• New methylene blue
• Phenothiazine structure
• Rember, investigational drug for Alzheimer's disease containing methylene blue
• Romanowsky stain
• Methyl violet
• Gentian violet
• Fluorescein
• Prussian blue
• Egyptian Blue
• Methyl blue
• Han Purple
• Potassium ferrocyanide
• Potassium ferricyanide

References

External links

• NIH - Methylene blue test
• Methylene blue at stainsfile

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. メトヘモグロビン血症の臨床的特徴、診断、および治療 clinical features diagnosis and treatment of methemoglobinemia
• 2. 色素内視鏡検査 chromoendoscopy
• 3. 心臓手術施行患者の術後合併症 postoperative complications among patients undergoing cardiac surgery
• 4. 婦人科外科手術における尿路損傷：評価およびマネージメント urinary tract injury in gynecologic surgery evaluation and management
• 5. 拡大内視鏡検査 magnification endoscopy

English Journal

• Methylene blue as an early diagnostic marker for oral precancer and cancer.

• Riaz A, Shreedhar B, Kamboj M, Natarajan S.SourceDepartment of Oral Pathology and Microbiology, Career Post Graduate Institute of Dental Sciences and Hospital, C-1111, Indiranagar, Lucknow, 226016 India.
• SpringerPlus.Springerplus.2013 Dec;2(1):95. Epub 2013 Mar 9.
• Oral cancer is one of the most common neoplasm's and is ranked eighth in the cancer incidence worldwide. Early detection is of critical importance because survival rates markedly improve. In vivo staining is a simple, inexpensive, and fairly sensitive method. Involved 120 patients (50 with Premalign
• PMID 23524482

• Enzyme-free and ultrasensitive electrochemical detection of nucleic acids by target catalyzed hairpin assembly followed with hybridization chain reaction.

• Liu S, Wang Y, Ming J, Lin Y, Cheng C, Li F.SourceCollege of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, People's Republic of China; College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, People's Republic of China.
• Biosensors & bioelectronics.Biosens Bioelectron.2013 Nov 15;49:472-7. doi: 10.1016/j.bios.2013.05.037. Epub 2013 Jun 12.
• An isothermal, enzyme-free and ultrasensitive protocol for electrochemical detection of DNA is proposed based on the ingenious combination of target catalyzed hairpin assembly and hybridization chain reaction (HCR) strategies for two-step signal amplification. The DNA hairpin assembly on the electro
• PMID 23811481

• Fabrication of a highly sensitive adenosine aptasensor based on covalent attachment of aptamer onto chitosan-carbon nanotubes-ionic liquid nanocomposite.

• Shahdost-Fard F, Salimi A, Sharifi E, Korani A.SourceDepartment of Chemistry, University of Kurdistan, 66177-15175, Sanandaj, Iran.
• Biosensors & bioelectronics.Biosens Bioelectron.2013 Oct 15;48:100-7. doi: 10.1016/j.bios.2013.03.060. Epub 2013 Apr 11.
• The present study describes the fabrication of a novel electrochemical aptasensor for the label-free determination of adenosine. The immobilization surface is prepared by the modification of a glassy carbon (GC) electrode with a robust nanocomposite containing multiwalled carbon nanotubes, ionic liq
• PMID 23660341

Japanese Journal

• Antimicrobial photodynamic activity and cytocompatibility of Au25(Capt)18 clusters photoexcited by blue LED light irradiation

• International Journal of Nanomedicine 12, 2703-2716, 2017-04-04
• NAID 120006024358

• Improving Effect of MnO₂ Addition on TiO₂-Photocatalytic Removal of Lead Ion from Water

• Journal of Water and Environment Technology 15(2), 35-42, 2017
• NAID 130005589259

• Influence of Mg dopant on photocatalytic properties of Mg-doped ZnO nanoparticles prepared by sol–gel method

• Journal of the Ceramic Society of Japan 125(3), 122-124, 2017
• NAID 130005401712

Related Links

• Methylene Blue Pure & USP Methylthioninium Chloride ...

Methylene Blue Pure & USP Manufacturers Methylthioninium Chloride BP IP Ph Eur Manufacturers Swiss Basic Urolene blue, Exports to Tanzania Kenya Uganda ... Anmol Chemicals is a several decades old manufacturing ...

• Amazon.com: methylene blue

Methylene Blue Stain/dye 10g Bottle High Purity by Consolidated Chemical & Solvents LLC 1 new from $10.00 Electronics: See all 12 items 12. Innovating Science Gram's Stain Kit by Innovating Science Buy new: $23.34 2 new ...

Related Pictures

---

★リンクテーブル★

リンク元	「メチレンブルー」「methylthioninium chloride」
拡張検索	「new methylene blue」
関連記事	「blue」「bluing」

「メチレンブルー」

　　[★]

英

methylene blue

同

メチルチオニン methylthionine、Urolene Blue

関

染色法、メトヘモグロビン血症

構造

• C16H18ClN3S。

強酸との塩なので、液性は塩基性

臨床関連

• 1. メトヘモグロビンの治療薬

intravenous methylene blue for methemoglobin fraction > 30%, symptomatic hypoxia, or ischemia (contraindicated in G6PD deficiency) (HIM. Chapter e35)

• 2. 染料

• 病理組織、検体の染色

参考

• 1. [charged] メトヘモグロビン血症の臨床的特徴、診断、および治療 - uptodate [1]
• 2. wiki ja

http://ja.wikipedia.org/wiki/%E3%83%A1%E3%83%81%E3%83%AC%E3%83%B3%E3%83%96%E3%83%AB%E3%83%BC

商品名

• メチレンブルー

会社名

• 第一三共

成分

• メチルチオニニウム塩化物水和物

薬効分類

• メトヘモグロビン血症治療剤

薬効

• 中毒性メトヘモグロビン血症を効能・効果とする新有効成分含有医薬品

「methylthioninium chloride」

　　[★]

塩化メチルチオニニウム

関

methylene blue

「new methylene blue」

　　[★] ニューメチレン青、ニューメチレンブルー、ニューメチレンブルー法

「blue」

　　[★]

• n.

• 青色、青

• adj.

• 青い

関

cyan

　 　 　 　 　 　 　 　 　 　 　

「bluing」

　　[★]

• n.

• ブルーイング、青味付け。反射防止